|

VItamin D in pregnanCy for prevenTion Of eaRlY Childhood Asthma

RECRUITINGPhase 3Sponsored by Professor Klaus Bønnelykke
Actively Recruiting
PhasePhase 3
SponsorProfessor Klaus Bønnelykke
Started2024-12-20
Est. completion2026-10
Eligibility
Age18 Years – 45 Years
SexFEMALE
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06570889

Summary

The overall aim of the study is to develop a nutritional preventive vitamin D supplementation strategy in pregnancy for early childhood asthma/persistent wheeze during the first three years of life as we hypothesize that supplementation in higher doses than recommended could reduce the risk of disease development.

Eligibility

Age: 18 Years – 45 YearsSex: FEMALEHealthy volunteers accepted
* Pregnant Danish women before week 26 with blood levels of EPA+DHA above 4.7% of total fatty acids
* No current vitamin D intake above the recommended 400 IU/day
* No endocrine-, heart-, kidney- or auto-immune disorders
* No disorders requiring treatment with blood thinning medication

Conditions11

AllergyAsthmaCognition Disorders in ChildrenCroupDevelopment, ChildEczemaFractures, BoneGastrointestinal InfectionPsychiatric DiagnosisRespiratory Tract Infections

Browse More Trials

Asthma trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.